🇰🇷 6-Furfuryladenine in South Korea

6-Furfuryladenine (kinetin) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

6-Furfuryladenine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in South Korea

Frequently asked questions

Is 6-Furfuryladenine approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for 6-Furfuryladenine in South Korea?

Marketing authorisation holder not available in our data.